Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

61.87
-1.9400-3.04%
Pre-market: 61.900.0300+0.05%04:18 EDT
Volume:1.41M
Turnover:87.63M
Market Cap:7.62B
PE:18.04
High:64.17
Open:64.06
Low:61.43
Close:63.81
Loading ...
Feb 23, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2021

Major Issues Report

8-K - Current report
Jan 11, 2021

Major Issues Report

8-K - Current report
Dec 08, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2020

Major Issues Report

8-K - Current report
May 04, 2020

Major Issues Report

8-K - Current report
Apr 09, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 24, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2020

Major Issues Report

Current report, item 5.02
Feb 24, 2020

Major Issues Report

Current report, item 2.02